This brand name is authorized in Japan
The drug PHOSRIBBON contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Monobasic sodium phosphate monohydrate
UNII 593YOG76RN - SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
|
|
|
|
2
Dibasic sodium phosphate anhydrous
UNII 22ADO53M6F - SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
|
|
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 3229103D1020 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
